Table 2.
Correlations between BDI-II symptom dimensions and cytokine levels in patients with HCV (HCV+; n = 16) and in the entire study sample (all participants; N = 23).
| Depressive Symptom Dimension | IL-1β1 | TNF-α1 | IL-10 | |||
|---|---|---|---|---|---|---|
| HCV+ | All | HCV+ | All | HCV+ | All | |
| Negative Cognitions | r = 0.622,
p = 0.010* |
r = 0.542,
p = 0.009* |
r = 0.554,
p = 0.032* |
r = 0.542,
p = 0.009* |
r = −0.137,
p = 0.612 |
r = −0.12,
p = 0.956 |
| Psychomotor Anhedonia | r = 0.397,
p = 0.128 |
r = 0.338,
p = 0.114 |
r = 0.593,
p = 0.020* |
r = 0.489,
p = 0.021* |
r = −0.095,
p = 0.727 |
r = 0.039,
p = 0.860 |
| Vegetative Symptoms | r = 0.396,
p = 0.129 |
r = 0.372,
p = 0.081 |
r = 0.636,
p = 0.011* |
r = 0.544,
p = 0.009* |
r = −0.535,
p = 0.033* |
r = −0.183,
p = 0.403 |
| Total BDI-II Score | r = 0.489,
p = 0.055 |
r = 0.439,
p = 0.036* |
r = 0.594,
p = 0.020* |
r = 0.565,
p = 0.006* |
r = −0.113,
p = 0.678 |
r = 0.042,
p = 0.848 |
1
These variables did not have normal distributions; therefore, related analyses were conducted using Spearman rho correlations. Pearson product moment correlations were conducted for all other analyses.
*
p < 0.05